Old Web
English
Sign In
Acemap
>
Paper
>
P-310Efficacy of FOLFIRI as a second-line in extrapulmonary poorly-differentiated neuroendocrine carcinoma
P-310Efficacy of FOLFIRI as a second-line in extrapulmonary poorly-differentiated neuroendocrine carcinoma
2019
C. Fabregat Franco
M. Nieva Muñoz
F.J. Pérez Martín
J.C. Ruffinelli
C. Santos-Vivas
Consuelo Sanchez
R. Salazar
A. Teule
Keywords:
Pathology
Oncology
Medicine
FOLFIRI
Carcinoma
Internal medicine
neuroendocrine carcinoma
second line
poorly differentiated
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]